Annual report
2269.TEDINET S100YILP
Period2025-04-01 → 2026-03-31
Filed2026-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.17T | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥1.15T | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥1.11T | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.06T | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.01T | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥93.3bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥84.7bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥96.6bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥82.0bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥76.0bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥74.2bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥94.0bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥68.0bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥82.5bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥35.1bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥50.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥50.7bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥69.4bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥87.5bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥38.8bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥54.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥1.26T | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥1.18T | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥1.21T | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.14T | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.12T | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥444.2bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥392.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥817.6bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥791.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥787.8bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥751.3bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥713.0bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥69.2bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥78.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥49.6bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥66.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥102.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥60.9bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥64.9bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥56.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥69.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥108.0bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥85.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥127.5bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥110.4bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥40.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥24.6bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥36.8bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥27.6bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥34.6bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥61.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥43.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥54.7bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥77.0bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥129.42 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥186.08 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.64 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥247.39 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥303.62 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,849.8 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,762.33 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,674.72 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,553.69 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,390.76 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 61.2% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.2% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.9% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.7% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.3% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 4.6% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.0% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.5% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 17,103 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 17,231 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 17,270 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 17,290 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 17,336 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥36.3bn | 2025-04-01 → 2026-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥48.7bn | 2024-04-01 → 2025-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥30.6bn | 2023-04-01 → 2024-03-31v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥28.1bn | 2022-04-01 → 2023-03-31v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥34.5bn | 2021-04-01 → 2022-03-31v | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥24.6bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥38.7bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥24.8bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥39.0bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥24.9bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥23.9bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥31.1bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥24.1bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥42.4bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥25.4bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥42.6bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥32.9bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥28.3bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥31.7bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥415.9bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥349.8bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥364.8bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥369.2bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥391.4bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥196.1bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥124.2bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥219.9bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥225.6bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥244.2bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥238.4bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥246.0bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.5bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥93.64 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥155.94 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥117.79 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.97 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.12 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥105 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥95 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥170 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥810.96 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥832.92 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥874.99 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥855.11 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥873.6 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 52.9% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.5% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.0% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.6% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.4% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.1% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.6% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.7% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.4% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 282,200,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 282,200,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 293,459,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 148,369,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 148,369,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 298 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 295 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 116 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 99 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 85 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥676m |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥399m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥1.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥1.4bn |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | −¥44.6bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥5.9bn |
| Foodreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥61.2bn |
| Foodreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥44.0bn |
| Foodreportable segment | employees | at 2026-03-31 | 9845 pure |
| Foodreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥942.9bn |
| Foodreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥941.5bn |
| Foodreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥1.4bn |
| Foodreportable segment | segment assets | at 2026-03-31 | ¥870.5bn |
| Foodreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥68.7bn |
| Pharmaceuticalsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥28.2bn |
| Pharmaceuticalsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥10.5bn |
| Pharmaceuticalsreportable segment | employees | at 2026-03-31 | 6953 pure |
| Pharmaceuticalsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥232.2bn |
| Pharmaceuticalsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥232.2bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥26m |
| Pharmaceuticalsreportable segment | segment assets | at 2026-03-31 | ¥435.9bn |
| Pharmaceuticalsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥30.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥89.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥54.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥1.18T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥1.17T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥1.31T |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥99.2bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥641m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥370m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥1.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥1.1bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | −¥39.2bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥4.7bn |
| Foodreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥36.6bn |
| Foodreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥44.9bn |
| Foodreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥925.6bn |
| Foodreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥924.4bn |
| Foodreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Foodreportable segment | segment assets | at 2025-03-31 | ¥835.3bn |
| Foodreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥64.6bn |
| Pharmaceuticalsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥17.3bn |
| Pharmaceuticalsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥9.7bn |
| Pharmaceuticalsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥229.7bn |
| Pharmaceuticalsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥229.6bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥20m |
| Pharmaceuticalsreportable segment | segment assets | at 2025-03-31 | ¥388.3bn |
| Pharmaceuticalsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥24.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥53.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥54.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥1.16T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥1.15T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥1.22T |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥89.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,891
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000MatsudaKatsunariMember | 64005 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000NagasatoToshiakiMember | 25900 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000YaoBunjiroMember | 54477 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000FurutaJunMember | 39465 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000HishinumaJunMember | 18550 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000MatsumuraMarikoMember | 2691 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000KawataMasayaMember | 3627 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000KuboyamaMichikoMember | 1813 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000PeterDPedersenMember | 1146 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000TamakiMasayoriMember | 7904 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000WatanabeYasushiMember | 5822 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000AndoMakotoMember | 13769 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E21902-000KomatsuMasakazuMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 239169 | |
| Number of male directors and other officers proposal | FilingDateInstant | 9 | |
| Number of female directors and other officers proposal | FilingDateInstant | 3 | |
| Ratio of female directors and other officers proposal | FilingDateInstant | 0.250 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E21902-000MatsudaKatsunariMember | 64005 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E21902-000NagasatoToshiakiMember | 25900 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E21902-000YaoBunjiroMember | 54477 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E21902-000HishinumaJunMember | 18550 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E21902-000KawataMasayaMember | 3627 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E21902-000KuboyamaMichikoMember | 1813 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E21902-000PeterDPedersenMember | 1146 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E21902-000OmaeYukoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E21902-000TamakiMasayoriMember | 7904 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E21902-000WatanabeYasushiMember | 5822 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E21902-000AndoMakotoMember | 13769 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E21902-000KomatsuMasakazuMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant | 197013 | |
| Audit fees reporting company | Prior1YearDuration | 141000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | 3000000 | JPY |
| Audit fees reporting company | CurrentYearDuration | 143000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | 12000000 | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | 139000000 | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | 145000000 | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 281000000 | JPY |
| Non audit fees total | Prior1YearDuration | 3000000 | JPY |
| Audit fees total | CurrentYearDuration | 288000000 | JPY |
| Non audit fees total | CurrentYearDuration | 12000000 | JPY |
| Audit fees reporting company network firms | Prior1YearDuration | － | JPY |
| Non audit fees reporting company network firms | Prior1YearDuration | 2000000 | JPY |
| Audit fees reporting company network firms | CurrentYearDuration | － | JPY |
| Non audit fees reporting company network firms | CurrentYearDuration | 0 | JPY |
| Audit fees consolidated subsidiaries network firms | Prior1YearDuration | 168000000 | JPY |
| Non audit fees consolidated subsidiaries network firms | Prior1YearDuration | 248000000 | JPY |
| Audit fees consolidated subsidiaries network firms | CurrentYearDuration | 170000000 | JPY |
| Non audit fees consolidated subsidiaries network firms | CurrentYearDuration | 85000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |